跳至主要内容
临床试验/ISRCTN21593740
ISRCTN21593740已完成不适用

Randomised controlled trial of the benefits of oral essential amino acids in haemodialysis patients at high risk for hospitalisatio

Recip AB (Sweden)0 个研究点目标入组 400 人开始时间: 2006年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients on maintenance haemodialysis for at least four months at high risk of hospitalisation. This is defined as:
  • a. no more than two weeks post discharge from an acute hospitalisation and a serum albumin below 4.0 g/dl
  • b. a serum albumin below 3.8 g/dl

排除标准

  • 1. Patients who have difficulties in taking pills, due to problems swallowing or intractable vomiting
  • 2. Patients who have a short time life expectancy or are awaiting non-cadaveric kidney transplantation

研究者

发起方
Recip AB (Sweden)

相似试验